Eating disorders: an overview of treatment responses and the potential impact of vulnerability genes and endophenotypes.

Abstract excerpt

Anorexia nervosa (AN), bulimia nervosa (BN) and binge-eating disorder (BED) are the three main eating disorders. Antidepressants, antipsychotics, anticonvulsants, prokinetic agents, opiate antagonists, appetite suppressants, tetrahydrocannabinol, cyproheptadine, zinc and ondansetron have been tested, and are frequently associated with psychological treatment. Selective serotonin reuptake inhibitors have a proven...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Feeding and Eating Disorders
• Share to Genetic Predisposition to Disease